The immunosuppressant cyclosporine A (CsA) is a specific pharmacological inhibitor of calcineurin, the Ca 2+ -calmodulin activated phospho-Ser/Thr-specific protein phosphatase. Although calcineurin-inhibiting compounds are applied for local treatment of psoriasis or atopic dermatitis in dermatological practice, little is known about the functions of calcineurin in epidermis-derived malignancies. We investigated the effects of CsA on two human melanoma cell lines, the metastasis forming HT168 and WM35 established from an RGP primary lesion. CsA of 2 μM lowered the enzyme activity by 50% and caused elevation in both mRNA and protein expression of calcineurin. Cell proliferation was diminished, as well as the cellular morphology and the actin organization were altered in both cell lines. CsA increased cell death moderately in both cell lines and reduced the metabolic activity of HT168 cells, but not that of WM35 cells. CsA also elevated the expressions of both Bcl-2 and ERK1/2. Fibronectin guided migration of HT168 cells was stimulated under the effect of CsA, while that of WM35 cells was reduced, moreover, HT168 cells switched from the expression of ß3 to ß1 integrin, but WM35 cells continued to express ß3. Based on our results we propose a multiple, partly malignancy-dependent role of calcineurin in these melanoma cell lines.
Introduction
Calcineurin or PP2B is a Ca-calmodulin activated phosphoSer/Thr-specific protein phosphatase, which was first detected in brain and skeletal muscle (1) , and is best known as a key regulator of T-lymphocyte activation via dephosphorylation and consequent nuclear translocation of the transcription factor: Nuclear Factor of Activated T-lymphocytes (NFAT) (2, 3) .
Pharmacological inhibitors of calcineurin, such as cyclosporine A (CsA), tacrolimus or pimecrolimus recently became popular in the dermatological practice for topic treatment of diseases of skin which accompany activation of T-lymphocytes, e.g. atopic dermatitis (4) . Local application of these compounds have no significant side effects (5) , but it is reported that long-term systemic application of calcineurin inhibitors as immunosuppressants following organ transplantations may increase the incidence of skin tumours, particularly squamous cell carcinoma (6) .
Some physiological roles of calcineurin played in keratinocytes have been reported recently. It serves as a factor in the regulation of the terminal differentiation of keratinocytes (7) and it modulates the DNA repair following UV irradiation (8) . Application of calcineurin inhibitors for the treatment of hypopigmentary skin disorders has also been suggested (9) , but the investigation of the physiological role of calcineurin in the biology of melanocytes, the pigment producing cells of epidermis, has just started (10) .
Melanocytes develop from neural crest during embryonic life and have intense ability of migration in this period. Differentiated melanocytes regularly do not proliferate or migrate in adult epidermis and are under tight control of keratinocytes (11) . Cutaneous malignant melanoma originating from the melanocytes of the epidermis, is a highly malignant variant of skin tumours with a very poor prognosis if it starts to form metastases, since melanoma cells are highly resistant to any kind of conventional chemotherapy or irradiation. The results of experiments carried out during the last two decades revealed that malignant transformation of melanocytes is associated with overexpression and/or overactivation of various Ser/Thr-specific protein kinases, e.g. protein kinase C (12) , protein kinase A (13) or MAP kinases (14) . The importance of these signal transduction molecules in the ethiopathogenesis of melanoma is underlined by the fact that pharmacological inhibitors of these enzymes are promising therapeutic drugs of this malignancy (15) (16) (17) . Although the presumed role of Ser/Thr-protein phosphatases in the altered signal transduction pathways is beyond question, 
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little is known about the function of these enzymes in the cellular mechanisms of melanoma cells. As changes of the intracellular Ca-concentration are reported to be involved in the different cellular functions of melanoma cells such as migration (18) or cellular viability (19) , it seems likely that calcineurin may play a role in the regulation of these processes.
The aim of our study was to investigate the possible role(s) of calcineurin in the major cellular functions of two human melanoma cell lines; one of which (HT168) represents an experimental model of a highly metastatic melanoma (20) , while the other (WM35) was isolated from a radial growth phase (RGP) primary lesion (21) , and might be a good model of a less malignant, non-metastatic type of this malignancy. We report herein that inhibition of calcineurin by CsA caused different alterations in the morphology, actin organization, proliferation, viability, as well as fibronectin guided migration of the two melanoma cell lines. Furthermore, we found that CsA increased both the expression and the phosphorylation of ERK1/2, and it also elevated the protein level of Bcl-2 and modulated the ß3 and ß1 integrin expression pattern of melanoma cells. Based on our findings we suggest a multiple role of calcineurin in melanoma cells which partly depends on the stage of malignancy.
Materials and methods

Cultures of melanoma cell lines.
Human melanoma cell line HT168 was selected from A2058 cell line according to its metastasis formation in immunosuppressed mice (20) , while WM35 was established from a primary cutaneous melanoma of radial growth phase (21) . Both cell lines were provided by Dr J. Tímár (National Institute of Oncology, Budapest, Hungary). Cells were cultured in RPMI culture medium (Sigma, Budapest, Hungary) supplemented with 5% foetal bovine serum (HyClone, South Logan, UT), 2 mM L-glutamine (Gibco, Gaithersburg, MD), penicillin (100 units/ml) and streptomycin (100 μg/ml) at 37˚C in the presence of 95% air and 5% CO 2 atmosphere and 80% humidity in 25 cm 2 flasks (Orange Scientifique, Braine-l'Alleud, Belgium) until approximately 70% confluence. Activity of calcineurin was inhibited by continuous application of 2 μM CsA (Sigma) starting 2 days before confluence.
Light microscopical morphology analysis. Melanoma cells of different experimental groups were cultured on the surface of rectangular coverglasses (Menzel-Gläser, Menzel GmbH, Braunschweig, Germany) placed into Petri dishes. After rinsing, cells were fixed in a 4:1 mixture of absolute ethanol and 40% formaldehyde, stained with haematoxylin and eosin (Sigma) and mounted in gum arabic. Photomicrographs of cells were taken using a Spot Advanced camera on a Nikon Eclipse E800 microscope (Nikon Corporation, Tokyo, Japan).
Immunocytochemistry. For immunocytochemistry cells were cultured on the surface of rectangular coverglasses as described above. For calcineurin immunocytochemistry cells were fixed in Sainte-Marie solution (22) and washed in 70% ethanol. After rinsing in PBS, cells were blocked with PBS supplemented with 1% bovine serum albumin, then incubated in a polyclonal Pan-calcineurin A antibody (Cell Signaling Technology, Danvers, MA) at a dilution of 1:400 at 4˚C overnight. For visualisation of the primary antibody, FITCconjugated anti-rabbit secondary antibody (Vector Laboratories, Peterborough, UK) was used at a dilution of 1:1000. Cultures were mounted in Vectashield Hard Set mounting medium (Vector Laboratories) containing DAPI to visualise the nuclei. To demonstrate actin, cells were fixed in acetone at -20˚C for 20 min. After washing at room temperature with calcium magnesium-free phosphate buffer solution (CMF-PBS), TRITC-Phalloidin (Sigma) was applied at a dilution of 1:300 (23) . Cultures were viewed by fluorescence microscopy (Nikon Eclipse E800, Nikon Corporation). All images were acquired using constant camera settings to allow comparison of staining intensities.
Migration assay. Cells were washed twice in CMF-PBS, harvested with 0.25% trypsin (Sigma) and resuspended in RPMI in a density of 2x10 5 cells/ml. Lower wells of Boyden chamber (Neuro Probe Inc., Gaithersburg, MD) were filled with 1 μl/ml human fibronectin (Sigma) dissolved in CMF-PBS and covered with a polycarbonate filter (Neuro Probe Inc.) containing pores with a diameter of 3 μm. Cell suspension (50 μl) was inoculated into the wells on the top of the membrane and the chamber was incubated for 3 h at 37˚C in a humidified atmosphere (5% CO 2 -95% air). Non-migrated cells were removed from the surface of the membrane and after fixation in methanol, migrated cells were stained with 1% toluidine blue (Sigma) dissolved in water (24) . Membranes were air-dried and mounted with gum arabic. Absolute cell numbers were counted using a light microscope.
Measurement of apoptosis using flow cytometry.
After 48 h of treatment with CsA, the amount of apoptotic cells was determined using an Annexin V DY647 kit (Central European Biosystems, Budapest, Hungary) (25) and the ratio of necrotic cells was measured after staining with propidium iodide (PI, Sigma). Untreated cells were used as control. After washing twice in CMF-PBS, cells were incubated in 10 μl Annexin V DY647 and/or PI at room temperature for 10 min. Before harvesting with 0.25% trypsin, cells were washed with Annexin V binding buffer or CMF-PBS. Cell pellets were resuspended in 1000 μl FACS buffer (PBS supplemented with 1% BSA and 0.05% NaN 3 ) and were analysed with a CyFlow ® space Flow Cytometer (Partec GmbH, Münster, Germany). Annexin V DY647 was monitored at 670 nm and PI was detected at 430 nm. Measurement lower threshold was set on cell-size particles. Analysis was performed using WinMDI 2.8 freeware (Joseph Trotter, http://facs.scripps.edu/). Quadrants of Annexin/PI density plots were set as follows: Annexin-/PI-; Annexin+/PI-; Annexin-/PI+; Annexin+/PI+ populations.
Measurement of cell proliferation with
3 H-thymidine labelling and mitochondrial activity with MTT-assay. Medium containing 1 μCi/ml 3 H-thymidine (185 GBq/mM 3 H-thymidine, Amersham Biosciences, Budapest, Hungary) was added to cells cultured in wells of 24-well plates for 16 h on 2nd day of CsA treatment. After washing with PBS, proteins were precipitated with ice-cold 5% trichloroacetic acid for 20 min. After washing with PBS again, cells were harvested using 0.25% trypsin for 30 min and collected with centrifugation at 2000 x g. The pellet was resuspended in 10 μl CMF-PBS and placed into wells of special opaque 96-well plates (Wallac, PerkinElmer Life and Analytical Sciences, Shelton, CT). The plates were placed in an exsiccator containing phosphorous pentoxide in order to absorb moisture. Prior to measurements, 50 μl scintillation solution (MaxiLight; Hidex Ltd., Turku, Finland) was added to each well and radioactivity was counted by a liquid scintillation counter (Chameleon Microplate Reader, Hidex Ltd., Turku, Finland). For investigation of mitochondrial activity, cells were cultured in wells of 24-well plates and MTTassays were performed measuring the absorption at 570 nm (Chameleon Microplate Reader).
Determination of cytosolic free Ca
2+ concentration. Measurements were performed on melanoma cell cultures with approximately 70% confluence using the calciumdependent fluorescent dye Fura-2 (TEFLabs, Inc. Austin, TX). Cell lines were transferred to 2 ml fresh RPMI medium containing 10 ml Fura-2-AM (10 μM) and 4 μl neostigmin (0.3 nM) to inhibit extracellular choline esterases. After 60 min of incubation at 37˚C in a CO 2 incubator, cultures were washed twice in Tyrode's solution (137 mM NaCl, 5.4 mM KCl, 0.5 mM MgCl 2 , 1.8 mM CaCl 2 , 11.8 mM Hepes, 1 g/l glucose, pH 7.4). Fura-2-loaded cells were placed on the stage of an inverted fluorescent microscope and viewed using a x40 oil immersion objective. Measurements were carried out in the above described Tyode's solution in a perfusion chamber using a dual wavelength monochromator (DeltaScan, Photon Technologies International, Lawrenceville, KY) equipment. Fluorescence was measured using excitation wavelengths of 340 and 380 nm and an emission wavelength of 510 nm. Cytosolic free Ca 2+ concentrations were calculated from the ratios of intensities (R = F340/F380) as described (26) .
Western blot analysis. Total cell lysates were examined by Western blot. Samples for SDS-PAGE were prepared by the addition of 100 μl of 5-fold concentrated electrophoresis sample buffer (20 mM Tris-HCl pH 7.4, 0.01% bromophenol blue dissolved in 10% SDS, 100 mM ß-mercaptoethanol) to cell lysates and boiled for 10 min. About 60 μg of protein was separated by 7.5% SDS-PAGE gel for detection of ERK1/2, p-ERK1/2, calcineurin, Bcl2, integrin ß1, and integrin ß3. Proteins were transferred electrophoretically to nitrocellulose membranes. After blocking in 5% non-fat dry milk in PBST (phosphate buffered saline with 0.1% Tween-20, 20 mM Na 2 HPO 4 , 115 mM NaCl; pH 7.4), membranes were washed and exposed to the primary antibodies overnight at 4˚C. Polyclonal anti-ERK1/2 antibody (Sigma) in 1:750, monoclonal anti-diphosphorylated-ERK1/2 (p-ERK1/2) antibody (Sigma) in 1:400, polyclonal anti-PP2B (Pan-calcineurin A) antibody (Cell Signaling Technology, Danvers, MA) in 1:400, monoclonal anti-Bcl2 antibody (Upstate, Dundee, Scotland, UK) in 1:500, monoclonal antiintegrin ß1 antibody (Chemicon-Millipore, Billerica, MA) in 1:400 and polyclonal anti-integrin ß3 antibody (Cell Signaling Technology, Danvers, MA) in 1:400 dilution were used. After washing for 30 min with PBST, membranes were incubated with secondary antibodies, anti-rabbit IgG (Bio-Rad Laboratories, CA) in 1:1000 dilution for ERK1/2, calcineurin and integrin ß3, anti-mouse IgG (Bio-Rad Laboratories) for Bcl2, p-ERK1/2 and integrin ß1 in PBS containing 1% non-fat dry milk for 1 h at room temperature. Signals were detected by enhanced chemiluminescence (Pierce, Rockford, IL) according to the instruction of the manufacturer.
RT-PCR analysis. For RT-PCR analysis, melanoma cells were washed three times with RNase-free physiological NaCl, then the cultures were snap-frozen in liquid nitrogen and stored at -70˚C. Cell cultures were dissolved in TRIzol (Applied Biosystems, Foster City, CA), and following addition of 20% RNase free chloroform (Sigma) samples were centrifuged at 10,000 x g for 15 min at 4˚C. Samples were incubated in 500 μl RNase free isopropanol at -20˚C for 1 h, total RNA was dissolved in RNase free water and stored at -70˚C. The assay mixture for reverse transcriptase reactions contained 2 μg RNA, 0.112 μM oligo(dT), 0.5 mM dNTP and 200 units of High Capacity RT (Applied Biosystems) in 1X RT buffer. The sequences of primer pairs for polymerase chain reaction were as follows: for calcineurin 5'-TAC CCT GCA GTT TGT GAA TT-3' and 5'-ATA TGT TGA GCA CAT TTA CCA-3', for ERK1/2 5'-CCA GAC CAT GAT CAC ACA GG-3' and 5'-CTC GTC ACT CGG GTC GTA AT-3', for Bcl2 5'-GGG TAC GAT AAC CGG GAG ATA-3' and 5'-GGC CGT ACA GTT CCA AG-3', for integrin ß1 5'-GCC TAC TTC TGC ACG ATG-3' and 5'-TAA ATG TCT GTG GCT CCC-3', for integrin ß3 5'-CGT CCT GAC GCT AAC TGA-3' and 5'-GGT AGT GGA GGC AGA GTA ATG-3', for GAPDH 5'-CCA GAA GAC TGT GGA TGG CC-3' and 5'-CTG TAG CCA AAT TCG TTG TC-3'. At defined annelation degrees 30 cycles were used and PCR products were analysed by electrophoresis in 1.2% agarose gel containing ethidium bromide (Amresco Inc., Solon, OH) and photographed with a gel documentary system (DNR Bio-Imaging Systems Ltd., Jerusalem, Israel).
Calcineurin activity assay. For calcineurin activity assays, cells were harvested and after centrifugation at 10,000 x g for 10 min at 4˚C, the supernatants were used for enzyme activity measurements. Activity of calcineurin was assayed by the release of 32 P i from 32 P-labelled protein phosphatase inhibitor-1 as it was described by Yang et al (27) with some modifications (28) . Radioactivity was determined by Cerenkov counting in a liquid scintillation counter.
Statistical analysis. Statistical comparisons between control and test samples were analyzed using Student's paired t-test for the cell migration, mitochondrial activity and proliferation assays.
Results
Both the expression and the activity of calcineurin are higher in the more malignant HT168 cells. As there are no data either on the expression or the enzymatic activity of calcineurin in melanoma cells, we first aimed to characterise these parameters in the two cell lines. Cells of both lines expressed mRNA and protein of calcineurin, but HT168 cells exhibited a higher level (Fig. 1a and b) as revealed by RT-PCR and Western blot analyses. Immunocytochemical studies showed diffuse cytoplasmic distribution of the catalytic subunit of calcineurin in both cell lines and a delicate nuclear signal was also visible in the majority of HT168 cells (Fig. 1c and e ). Beside its higher protein level, the enzymatic activity of calcineurin was also significantly higher in cells of HT168 (Fig. 1g) . Since activity of calcineurin is regulated by Ca 2+ / calmodulin, we also determined the basal cytosolic free Ca 2+ concentration of melanoma cells. With Fura-2 loading, approximately 180-200 nM intracellular free Ca 2+ was detected in both cell lines (Fig. 1h) .
CsA influenced expression, activity and distribution of calcineurin. CsA, continuously present in the culture medium, significantly lowered the activity of calcineurin in both cell lines, although the inhibition was more pronounced in HT168 cells (Fig. 1g) . Parallel to this finding, we observed a probably compensatory elevation in the expression of calcineurin at mRNA and protein levels ( Fig. 1a and b) . CsA did not alter the diffuse cytoplasmic distribution of calcineurin as revealed by immunocytochemistry, but the signal was stronger in the cytoplasm of treated cells than in the control ones, furthermore, the granular nuclear signal was diminished by CsA treatment (Fig. 1d and f) .
Inhibition of calcineurin alters cell proliferation, viability and cell death. Cell proliferation and mitochondrial activity are sensitive parameters to monitor the cytotoxic effects of any pharmacological interventions. Both proliferation and mitochondrial activity were higher in HT168 cells than in WM35 cells under control conditions (Fig. 2a and b) . CsA treatment significantly reduced proliferation in both cell lines, although HT168 cells responded more prominently than WM35 (Fig. 2a) . Furthermore, repression of mitochondrial activity was also observed indicating the reduced viability of cells. The decrease was significant in HT168 cells and only non-significant effect was detected in WM35 cells (Fig. 2b) . CsA caused moderate increase of cell death as it was detected by FACS analyses using Annexin V or propidium iodide incorporation methods (Fig. 2c) . directed migration of tumour cells is an accepted in vitro model to simulate and estimate the invasiveness and mobility in tissues. As fibronectin is present both in the basement membrane of epidermis and in the extracellular matrix of dermal connective tissue, as well as in the majority of tumour matrices, it seemed to be a good candidate to use as a chemoattractant in Boyden chamber for migration assays of melanoma cells. Significantly higher number of HT168 cells migrated through the polycarbonate membrane toward fibronectin under control conditions compared to WM35 cells (Fig. 3) . Application of CsA in the culturing medium of melanoma cells prior to the migration assay had opposite effects; migration of HT168 cells was facilitated, while that of WM35 cells was inhibited as revealed by counting of migrated cells (Fig. 3 ). An identical effect was observed when CsA was present in the culturing medium during the migration assay (data not shown).
Opposite effects of
CsA modulates cell shape and actin organization of melanoma cells. Simultaneous changes of cell shape and reorganization of actin cytoskeleton are key elements in the migration of cells. Since inhibition of calcineurin had significant effect on fibronectin directed migration of melanoma cells, we investigated the morphology and the organization of actin network when CsA was applied. Untreated HT168 and WM35 cells exhibited pronounced morphological differences. High cellular polymorphism including giant cells with probably polyploid nuclei were characteristic in the more malignant HT168, whereas more uniform spindleshaped and multipolar cells were visible in the less malignant cell line (Fig. 4a and c) . CsA caused dramatic morphological changes in both cell lines. The majority of cells in HT168 became more elongated and gained longer processes, WM35 cells lost their long extensions and became more compact under the effect of CsA. Additionally, cytoplasm of WM35 cells became somehow 'foamy-like'. Furthermore, compaction of nuclei and a decreased number of nucleoli were observed in both cell lines (Fig. 4b and d) . Actin network of untreated HT168 cells formed well defined stress fibers which became thicker and more developed in the presence of CsA (Fig. 4e and f) . Untreated WM35 cells did not exhibit pronounced actin cables and only a few delicate stress fibers appeared under the effect of CsA (Fig. 4g and h ).
ß1 and ß3 integrin, Bcl-2 and ERK1/2 expressions in melanoma cell lines. As cells can attach to fibronectin mainly via ·5ß1 and ·5ß3 integrins, we investigated the expression of ß1 and ß3 integrin subunits in melanoma cells. We found that both cell lines express more ß3 than ß1 subunit proteins and the difference was very prominent in the case of WM35 cells (Fig. 5b) . Treatment of cells with CsA resulted in opposite effects in the two different cell lines. WM35 cells did not show any significant change in the protein level of either ß1 or ß3 subunits, while cells of HT168 did change their protein expression pattern: stronger ß1 and weaker ß3 protein signals were detected as compared to the untreated cells (Fig. 5b) . None of the afore-mentioned differences were detected at the mRNA level (Fig. 5a ). Apoptosis resistance is one of the worst biological properties of melanoma cells, therefore we investigated the expression of the anti-apoptotic Bcl-2 and also the expression and phosphorylation levels of ERK1/2. The latter molecule is widely accepted as one of the most important factors responsible for the apoptosis resistance of melanoma cells (29) . Similarly to the results observed for integrins, the changes of Bcl-2 or ERK1/2 were only detected at protein levels, mRNA expressions exhibited no significant alterations (Fig. 5a) . Despite this fact, we detected differences either in the protein level or in the phosphorylation status of ERK1/2 in control and CsA-treated cells. We did not detect any significant difference in the expression levels of ERK1/2 of the two cell lines under control conditions. Inhibition of calcineurin resulted in a significant elevation of unphosphorylated ERK1/2 in both cell lines and an extremely pronounced level of dual-phosphorylated ERK1/2 appeared in HT168 cells (Fig. 5b) . Bcl-2 protein was somewhat less expressed by WM35 cells than that of HT168 cells under control conditions, but both cell lines responded to CsA treatment with a slight increase of Bcl-2 protein level (Fig. 5b) .
Discussion
Our data provide evidence for the presence and the activity of calcineurin, furthermore, some possible targets of the enzyme are also suggested in HT168 and WM35 human melanoma cell lines. The two cell lines did not exhibit pronounced differences either in mRNA or protein levels of calcineurin, but a much higher enzyme activity was detected in HT168 cells. Activity of calcineurin is dependent on changes of the intracellular Ca-concentration. The basal cytosolic-free Ca-concentration was found 180-200 nM in both cell lines, which value is in line with that of reported by Hodgson and Dong (30) in A2058, the parental cell line of HT168. The half-maximal activation of calcineurin could require higher Ca-concentration (400-600 nM), at least in enzyme activity assay (31) . Therefore, we may suppose periodic activation of different Ca-channels either in the plasma membrane or in the endoplasmic reticulum of melanoma cells, since oscillations of intracellular Ca-concentration are also reported to sensitize cells to Ca-signalling (32) . Another possibility is that Ca-independent regulatory molecules of calcineurin, such as calcipressin, binding to the regulatory subunit of calcineurin or cabin1 interacting with activated calcineurin may be involved in the modulation of its activity in melanoma cells (33) .
CsA is perhaps the best known pharmacological inhibitor of calcineurin, thus we applied this drug to investigate the possible effects of calcineurin in melanoma cells. Some cellular functions were modulated in opposing directions in the two cell lines. Viability assays detected significant cytotoxicity on HT168 cells in the presence of CsA, while WM35 cells did not respond so. This observation may reflect that more malignant melanoma cells are more sensitive to the inhibition of calcineurin function. In some aspects the two cell lines responded to CsA treatment similarly. Activity of calcineurin was lowered by 30-50%, proliferation of melanoma cells was attenuated by 50% and the rate of cell death was moderately affected. Furthermore, CsA caused pronounced alterations in the morphology of both cell lines, although the direction of these changes proved to be different. HT168 cells became more elongated, while WM35 cells lost their processes and became rather polygonal. This observation is partly in line with those described by Hojo et al (34) who found that CsA treatment of pulmonary adenocarcinoma cell line A-549 resulted in morphological changes including formation of membrane ruffling and numerous pseudopodial protrusions. We also observed that nuclei of cells became more compact and less nucleoli were visible in each individual nucleus.
The profound effect of CsA treatment on the morphology of cells of both cell lines raised the possibility of the modulation of mobility/invasiveness of melanoma cells. It is well known that mobility of different cells including those of malignant phenotype is promoted by multiple factors such as adhesion to the extracellular matrix molecules or changes of intracellular Ca-concentration (18, 35) . In some cases simultaneous involvement of the two events were also reported, e.g. type IV collagen stimulated intracellular calcium in the A2058 human melanoma cell line (36) , however, fibronectin failed to induce the same change. On the other hand, results of Hodgson and Dong (30) elucidated an other aspect of the relationship of adhesion/migration and intracellular Ca. Type IV collagen guided migration of A2058 cells was found effectively abrogated by increased intracellular calcium concentration. Nonetheless, both groups (30, 36) have suggested the implication of calcineurin in the altered guided migration of melanoma cells. Therefore, we investigated the effect of the inhibition of calcineurin on the fibronectin guided migration of the two melanoma cell lines. We found that CsA had pronounced promoting effect on the chemotaxis of HT168 cells. On the other hand, WM35 cells were significantly inhibited in their migration ability by this compound. Influence of CsA on the migration and the invasiveness of several tumour types was recently investigated yielding different results. Sliwa et al (37) reported inhibition of migration of glioblastoma cells treated by CsA and Yiu and Toker (38) found that CsA inhibited the migration of breast cancer cells in an NFAT-and COX-2-dependent manner. On the contrary, motility and invasiveness of lung adenocarcinoma cell line was stimulated by CsA (34) . These contradictory observations might be explained if we suppose a cell type-and progression-dependent influence of calcineurin on the migration ability of different tumour cells.
There are several observations describing the role of calcineurin in the reorganization of actin network of different cell types, such as neurons (39) or neutrophil granulocytes (40, 41) . We also found that beside changes in morphology of melanoma cells, CsA caused pronounced alterations of actin network in HT168 cells. The opposite response of the two cell lines in changes of morphology, actin reorganization and chemotaxis may imply the possibility of different target molecules of calcineurin in the two different phases of progression of melanoma.
Adhesion to the tumour matrix molecules and the chemotaxis of malignant cells are influenced by the expression pattern of receptors to extracellular matrix molecules, such as integrins (42) . Integrin signalling of melanoma cells is extensively investigated (43) and a wide range of different integrins is referred to be present in them. According to our Western blot analysis, both cell lines express more ß3 than ß1 integrin subunits. It is accepted that melanocytes do not express ß3 but possess ß1 integrins and during development of melanoma, the appearance of ß3 integrins is a specific marker of transition from radial growth phase to vertical growth phase (44) . CsA altered the integrin expression profile in the two cell lines: HT168 cells switched from ß3 to ß1 integrins, while WM35 cells kept expressing ß3 integrins. To find the biological implication of this opposite response requires further investigations, particularly if we consider the fact that fibronectin guided migration of HT168 cells was stimulated, while that of WM35 cells was inhibited by CsA. Nonetheless, it is possible that the difference in the change of the integrin pattern of melanoma cells in response to CsA treatment may reflect the involvement of malignancy stagedependent role of calcineurin in the regulation of fibronectin guided migration of melanoma cells.
Beside their high motility, another biological property providing poor prognosis of melanoma is the high resistance of the melanoma cells to apoptosis. Sustained overactivation of MAPKK/ERK pathway is regarded as one of the factors which protect melanoma cells against apoptosis inducing chemotherapies. In human keratinocytes, CsA is described to decrease DNA repair and apoptosis following UV irradiation (8) and indeed, we found that CsA did not cause significant cell death either in HT168 or WM35 cells. Parallel to this, expression and phosphorylation of ERK1/2 was extremely elevated in CsA treated cells. Moreover, CsA caused increased expression of anti-apoptotic Bcl2. These data support the idea that calcineurin might be an important factor in the regulation of apoptosis in melanoma cells, although inhibition of calcineurin alone did not cause significant alteration of cell death. Nonetheless, CsA has been described to augment the apoptotic effect of taxol in urinary bladder cancer cells (45) and modulation of intracellular calcium level with depleting intracellular Ca-stores also caused a calcineurin-dependent apoptosis in prostatic cancer cells (46) .
In conclusion, calcineurin plays multiple roles in the different cellular functions of the two human melanoma cell lines investigated. Our observations may point out the involvement of calcineurin in the malignant transformation of melanocytes in vivo, which is independent from the alteration of T-lymphocyte function. This idea is supported by data of Hojo et al (34) , drawing our attention to the possible immunosuppression-independent role of calcineurin in the development of malignant phenotype of different cell types.
